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Abstract
Background: Shiga toxin-producing Escherichia coli O157:H7 is a foodborne pathogen that causes severe human
diseases including hemolytic uremic syndrome (HUS). The virulence factor that mediates HUS, Shiga toxin (Stx), is
encoded within the genome of a lambdoid prophage. Although draft sequences are publicly available for a large
number of E. coli O157:H7 strains, the high sequence similarity of stx-converting bacteriophages with other
lambdoid prophages poses challenges to accurately assess the organization and plasticity among stx-converting
phages due to assembly difficulties.
Methods: To further explore genome plasticity of stx-converting prophages, we enriched phage DNA from 45
ciprofloxacin-induced cultures for subsequent 454 pyrosequencing to facilitate assembly of the complete phage
genomes. In total, 22 stx2a-converting phage genomes were closed.
Results: Comparison of the genomes distinguished nine distinct phage sequence types (PSTs) delineated by
variation in obtained sequences, such as single nucleotide polymorphisms (SNPs) and insertion sequence element
prevalence and location. These nine PSTs formed three distinct clusters, designated as PST1, PST2 and PST3. The
PST2 cluster, identified in two clade 8 strains, was related to stx2a-converting phages previously identified in non-
O157 Shiga-toxin producing E. coli (STEC) strains associated with a high incidence of HUS. The PST1 cluster
contained phages related to those from E. coli O157:H7 strain Sakai (lineage I, clade 1), and PST3 contained a single
phage that was distinct from the rest but most related to the phage from E. coli O157:H7 strain EC4115 (lineage I/II,
clade 8). Five strains carried identical stx2a-converting phages (PST1-1) integrated at the same chromosomal locus,
but these strains produced different levels of Stx2.
Conclusion: The stx2a-converting phages of E. coli O157:H7 can be categorized into at least three phage types.
Diversification within a phage type is mainly driven by IS629 and by a small number of SNPs. Polymorphisms
between phage genomes may help explain differences in Stx2a production between strains, however our data
indicates that genes encoded external to the phage affect toxin production as well.
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Background
Shiga toxin-producing Escherichia coli (STEC) O157:H7
is a food- and waterborne human pathogen that causes
diarrhea, hemorrhagic colitis (HC), or in more severe
cases hemolytic uremic syndrome (HUS) [1, 2]. Cattle
are the primary reservoir of this pathogen and may be
asymptomatically colonized [3]. Due to the serious dis-
ease and its low-infectious dose [4], E. coli O157:H7 is
considered an adulterant in non-intact raw beef prod-
ucts in the United States. Shiga toxin (Stx) is one of the
major virulence factors involved in E. coli O157:H7
pathogenesis [5]; based on immunoreactivity, toxins are
classified as either Stx1 or Stx2 [6]. DNA sequence di-
versity further divides Stx2 into 7 allelic types (Stx2a
through Stx2g) [7] with Stx2a and Stx2c most frequently
associated with HUS [8, 9]. During the stepwise evolu-
tion of E. coli O157:H7 from a common E. coli O55:H7
ancestor, genes encoding Stx1 and Stx2 were acquired
horizontally by phage transduction [10]. In this estab-
lished model, the stx2-converting phage was acquired
before the antigenic shift from O55 to O157, followed
by stx1-converting phage acquisition. Follow-up studies
refined this model [11, 12] and most recently, Lacher et al.
[13] proposed a model taking into consideration acquisi-
tion and loss of stx1-, stx2a-, and stx2c-converting phage,
and additional mutations that define E. coli O157:H7 sub-
lineages. Genetic characterization together with clinical
data has identified that two groups, designated clade 6 and
clade 8, are more commonly associated with severe disease
than are isolates from other clades [14, 15].
The lambdoid stx-converting phages are temperate,
exhibiting both lytic and lysogenic life cycles [16]. The
lysogen-lytic switch is directed by several regulatory
proteins including cI, cII, cIII, cro, N, and Q, the latter
of which activates transcription from the late promoter,
pR’. The genes encoding Stx2 are positioned downstream
of pR’ [17], and DNA damaging agents that activate lytic
replication also increase toxin production [18]. Previous
genomic analyses [19, 20] demonstrated that DNA se-
quence variation between stx2-converting phages occurs
particularly within the regulatory regions, leading to the
hypothesis that differences in the kinetics and abundance
of prophage induction may be responsible for the varia-
tions in Stx2 production observed between different E. coli
O157:H7 strains [21, 22]. This is supported by the obser-
vation that the E. coli O157:H7 Q allele designated Q933 is
a marker of high Stx2a producing strains [23], although
this has not been seen in other isolate collections [24].
Other factors impacting toxin production include the
presence of insertion sequences (IS) [24–26] within the
phage genomes, and cI repressors encoded within other
prophage [27].
In previous publications we characterized 52 E. coli
O157:H7 isolates from patients in Pennsylvania [28] and
sequenced the genome of three isolates [29]. While the
whole-genome sequence (WGS) data provided valuable
information concerning strain diversity, the stx-converting
phage genomes, critical for understanding toxin produc-
tion, could not be fully assembled. Factors contributing to
this include the short read technology used, and the high
sequence identity with other lambdoid phages; e.g. 13 out
of 18 prophages in E. coli O157:H7 Sakai are classified as
lambdoid [30]. The objectives of the present work were to
isolate and sequence stx2a-converting phages from a di-
verse set of E. coli O157:H7 strains, and to compare these
phage genomes to those previously sequenced; the identi-
fication of identical phage within different E. coli O157:H7
hosts also allowed us to test whether factors encoded out-
side of the phage genome impact Stx2 production.
Results
Phage genome assemblies
To enrich phage DNA (phDNA), E. coli O157:H7 strains
were induced by ciprofloxacin and total phDNA was
isolated. For 22 of the 45 strains, sufficient dsDNA
(≥200 ng) was obtained for 454 sequencing, and
assembly resulted in complete stx2a-converting phage
genomes ranging in size from 61,292 to 65,334 bp
(Table 1, Additional file 1: Table S1). In addition, two
15,957 bp phage genomes unrelated to stx2a-converting
phage and inserted at yicC, yielded enough read coverage
for complete phage assembly.
Twenty-two stx2a-converting phage genomes form three
genetic clusters
Predicted phage proteomes were compared with Large
Scale Blast Score Ratio (LS-BSR) [31]. Applying hierarchical
average linkage clustering algorithm, which is part of MeV
v.4.8 [32], on this proteomic matrix (Pearson Correlation)
[33] identified three distinct phage clusters, designated as
Phage Sequence type 1 (PST1), PST2 and PST3 (Fig. 1).
These three clusters were also apparent within a whole
genome alignment (Additional file 2: Figure S1). The 19
genomes classified as PST1 were further divided into six
subtypes (PST1-1 to PST1-6) by assessing IS629 copy num-
ber and insertion sites (Fig. 2a). PST1-1 contained 13 phage
genomes that each have IS629 inserted at the same position
(nucleotides 24,350–25,659), splitting a predicted phage
protein into two predicted proteins (as an example, those
with protein_id AKI86024 and AKI86027 in the PA4 phage
GenBank entry, KP682372). This insertion sequence is
located downstream of the stx2 gene. Genome sequences
of the 62 kb PST1-1 phage differed at most by five SNPs,
and these SNP level differences were observed within the
predicted OR2 operator, portal protein, tail fiber, and sev-
eral hypothetical proteins (Additional file 3: Table S2). All
PST1-1 isolates carry the stx2a-converting prophage
found in the prototypical strain E. coli O157:H7 Sakai
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[30]. The two phages in PST1-2 were 100 % identical
on the nucleotide level, and PSTs 1–3, −4, −5, and −6
each represent single phage found in strains PA27,
PA36, PA45, and PA52, respectively.
We found that all PST1 cluster phages inserted within
wrbA, which encodes a TrpR binding protein, while both
the PST2 and PST3 cluster phages were inserted within
the tRNA argW (Table 1). The int sequences were identi-
cal for the PST2 and PST3 cluster phages. However, these
were clearly of different evolutionary origin or have sub-
stantially diverged from int encoded within PST1 cluster
phage, as neither the DNA nor the deduced amino acid
sequences could be aligned using BLAST [34]. A correl-
ation between int sequences and insertion site has been
noted before [35].
IS629 insertion and position is a main driver of genetic
variation observed within PST1 and PST2 clusters
Genomes from the PST1 phage cluster ranged in size
from 61,388 to 65,334 bp (Table 1). IS629 copy num-
bers, ranging from 0 (PST1-2) to 3 (PST1-5 and PST1-
6), accounted for most of this difference. The insertion
site and orientation of IS629 varied as well (Fig. 2a and
Additional file 4: Table S3). For instance, for PSTs 1–3
and 1–6, the transposon inserted at position 25,663, inter-
rupting the gene for a putative DNA-binding protein Roi.
IS629 also inserted at position 28,390 in PST1-5, inter-
rupting a putative lysozyme, and at position 2456 in
PST2-1, interrupting a putative adenine DNA methyl-
transferase. In PST2-2, the insertion was found at pos-
ition 31,540 within an intergenic region (Fig. 2b and
Additional file 4: Table S3).
Phage early regulatory and replication regions differed
among the three clusters
We next performed a global alignment of representative
phage genomes from PST1, PST2, and PST3 (Fig. 3). Most
differences were observed within regions predicted to
encode the phages’ early regulatory and replication genes.
For example, cI (annotated as protein_id AKI86003 in
the PST1-1 phage from PA4, AKI85932 in the PST2-1
phage from PA2, and AKI86748 in the PST3-1 phage
from PA28) and cro (protein_id AKI86003 in the PA4
phage, AKI85933 in PA2, and AKI86749 in PA28) only
shared 9.8–49.8 % amino acid sequence identity over the
full gene length among the three clusters (Additional file
5: Table S4). Homologs that were distantly related by
amino acid identity could still be identified by their shared
patterns defined in the Clusters of Orthologous Groups
database [36]. Predicted operator sequences [37, 38] were
identified between cI and cro (OR1, OR2, and OR3) and
between cI and N (OL1, OL2, and OL3) in genomes of the
PST1 and PST3 cluster (Additional file 6: Table S5). We
could not identify putative operator sequences or homo-
logs to the early regulatory genes cIII and cII in the PST2
cluster, but instead a type II restriction/modification
enzyme system (bsuBI) was found at the corresponding
region.
The sequence divergence within predicted early regula-
tory and replication genes is contrasted by the conserva-
tion of predicted late and structural genes. For instance,
one of the late genes encoding a putative lysozyme (protei-
n_id AKI86033 in PA4, AKI85950 in PA2, and AKI86778
in PA28), shared 95–98 % amino acid sequence identity
over the full gene length among the 3 clusters (Additional
file 5: Table S4).
The PST2 cluster is more closely related to the
stx2a-converting phage of E. coli O104:H4 2011C-3493
rather than to PST1 and PST3
Phage genomes were extracted from 10 closed bacter-
ial genomes deposited in GenBank (Additional file 7:
Table S6), and we compared these to the nine PSTs
established in this study and to seven other representa-
tive stx2a-converting phages from the E. coli O157:H7
lineage and non-O157 serotypes. We identified sequence
fragments present in at least 3 of the 24 genomes using
Panseq [39], and their distribution, presence or absence,
Table 1 Genome size, genomic insertion site, IS629 copy number, and host strain(s) for the nine Phage Sequence Types (PSTs)
defined in this study
PST Genome Size (bp) Insertion site IS629 copy number Host Strain(s)
1-1 62708 wrbA 1 PA4, PA5, PA11, PA16, PA18, PA21, PA29, PA30, PA32, PA33, PA42, PA44, PA50
1-2 61388 wrbA 0 PA12, PA51
1-3 64021 wrbA 2 PA27
1-4 64021 wrbA 2 PA36
1-5 65334 wrbA 3 PA45
1-6 65334 wrbA 3 PA52
2-1 63569 tRNA(argW) 1 PA2
2-2 63584 tRNA(argW) 1 PA8
3-1 61292 tRNA(argW) 2 PA28
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Fig. 1 (See legend on next page.)
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in each phage genome was used to infer a neighbor-
joining tree [40] using SplitsTree 4 (Fig. 4). The PSTs
within a cluster were located on the same node and this
PST2 cluster was more related to stx2- phages from highly
virulent non-O157 strains, such as E. coli O104:H4
2011C-3493 [41], O103:H2 [42], and O103:H25 [43] when
compared to PSTs 1 or 3.
BLAST comparisons [34] were performed between
representative PSTs from each of the 3 clusters and the
nearest neighbor from Fig. 4. PST1-1 and the EDL933
stx2a- phage [19], differed mainly within the predicted
phages’ early regulatory and replication region (Fig. 5a,
Additional file 8: Table S7). For PST2-1 and the phage in
strain E. coli O104:H4 2011C-3493, phage regulatory and
replication regions showed a higher degree of similarity
(Fig. 5b, Additional file 8: Table S7). Noteworthy, the
bsuBI restriction/modification system in PST2-1 is also
present in the O104:H4 2011C-3493 phage genome [41].
Most differences between the two phages were found
within regions encoding ORFs with no assigned functions.
The most evident difference between PST3-1 and the
EC4115 phage was within a region encoding genes for N,
cI, and cro (Fig. 5c, 78).
E. coli O157:H7 host genome affects Stx2 production
Our analyses identified for the first time strains of E. coli
O157:H7 (PA4, PA18, PA30, PA33, and PA44) carrying
stx2a-converting phages (PST1-1) that were 100 % iden-
tical on the phDNA level and had the same insertion site
(wrbA). These strains also carry an stx1-converting
phage [28]. This provided us with the unique opportun-
ity to use non-manipulated strains to ask whether factors
Fig. 2 IS629 is responsible for most diversity observed within (a) PST1 and (b) PST2 clusters. BLAST comparisons of phage genomes were
visualized using Easyfig [77]. Blue shaded regions connect homologous sequences and orange shaded regions connect reverse complemented
homologous sequences. Arrows represent ORFs. Dark pink and green arrows designate the location of stx2a and IS629, respectively
(See figure on previous page.)
Fig. 1 Nine phage sequence types (PSTs) form three clusters when compared at the proteomic level. De novo gene prediction with prodigal was
used to have consistent ORF prediction prior to tblastn analysis. Resulting LS-BSR values were clustered by average linkage hierarchical clustering
resulting in three distinct main phage clusters (PST-1, PST-2, PST-3). Five proteins were highly conserved in PST2, 4 in PST3 and 6 in PST1, and
almost 50 % of proteins are conserved in all phages. The LS-BSR for each ORF identifies unique (Blue = 0), divergent (Black = 0.5) and common
proteins (Yellow = 1.0) [87]
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Fig. 3 The three PST clusters differ mainly in the early regulatory and replication regions. BLAST comparisons of phage genomes were visualized
using Easyfig [77]. Blue shaded regions connect homologous sequences and orange shaded regions connect reverse complemented
homologous sequences. Arrows represent ORFs. Light orange, light blue and light yellow arrows represent early regulatory genes,
replication genes and antiterminator Q, respectively. Light pink arrows represent bsuBI restriction/modification system. Dark pink and
green arrows designate the location of stx2 and IS629, respectively
Fig. 4 Phages of PST2 are related to those from strains associated with high HUS rates. Host strain names or phage names are indicated. Phage
genomes were cut into 500 bp fragments. The “Core genome” was defined as fragments present in >2 phage genomes at > 85 % identity using
Panseq [39]. The presence or absence of core genome fragments in each phage genome was used for clustering. Uncorrected P-distance was
used to build a neighbor-joining tree using SplitsTree 4 [80]. PST1, PST2, and PST3 clusters are highlighted by yellow, light purple and orange
shading, respectively
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apart from the stx2a-converting phage genome impact
toxin production. To first investigate the genetic related-
ness of the host strains, we established a phylogenomic
framework derived from whole genome alignments of
shared regions, excluding prophage, for all 45 E. coli
O157:H7 genomes [44, 45] (Fig. 6). Strains PA4, PA18,
PA30, PA33 and PA44 are phylogenetically positioned
on separate branches indicating that, as expected, no
two chromosomes genomes were identical. Next, we
measured the Stx2a levels and stx2a expression after cip-
rofloxacin phage-induction (Fig. 7a). The lowest Stx2a
producer was PA4, at approximately 1 ng/μg of protein,
and the highest producer was PA44, at approximately
5 ng/μg of protein. PA18 produced 3.2 ng/μg, which was
significantly different from the previous two strains,
while toxin production from strains PA30 (4.4 ng/μg)
and PA33 (4.6 ng/μg) was only different from PA4. Sur-
prisingly, stx2a transcript levels were similar for all
strains except for PA18, which was greater than 10-fold
above that measured with PA4, PA30, PA33, or PA44
(Fig. 7b). This observed disconnect indicates that qPCR
does not always reflect the level of Stx2 secreted by E.
coli O157:H7.
Discussion
The progression and severity of HUS is thought to cor-
relate with the amount of Stx2 produced by E. coli
O157:H7 [46]. E. coli O157:H7 strains vary by their toxin
production potential and this likely results in different
virulence potentials [22, 47]. Molecular methods previ-
ously grouped E. coli O157:H7 strains into three lineages
and nine clades [14, 48, 49]. Lineage I has been more
frequently observed with isolates of human origin (at
least in the United States) than were lineage I/II or
lineage II isolates [48, 49]. This is presumably due, in
part, to higher levels of Stx2 produced by lineage I iso-
lates compared to other lineages [22]. As production of
Stx2 is directly linked to phage replication [50], it is not
surprising that we were most successful in isolating
phDNA for sequencing from lineage I isolates. We only
obtained sufficient DNA from 3 out of 12 clade 8
(lineage I/II) strains, which some reports suggested are
Fig. 5 Alignment of PST1-1, PST2-1, and PST3-1 to related phage from E. coli O157:H7 strains Sakai, O104:H4 2011C-3493, and EC4115, respectively.
BLAST comparisons of (a) PST1-1 and phage from EDL933, (b) PST2-1 and phage from O104:H4 2011C-3493 and (c) PST3-1 and phage from
EC4115 were visualized using Easyfig [77]. Blue shaded regions connect homologous sequences and orange shaded regions connect reverse
complemented homologous sequences. Arrows represent ORFs. Light orange, light blue and light yellow arrows represent early regulatory genes,
replication genes and antiterminator Q, respectively. Light pink arrows represent bsuBI restriction/modification system. Dark pink and green arrows
designate the location of stx2 and IS629, respectively
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high Stx2 producers [51], although another study [22]
suggested Stx2 levels are at least one-log less than
lineage I isolates. We were also unable to isolate suffi-
cient phDNA from lineage II (clade 7) isolates (PA40,
PA41) or from a clade 9 isolate (PA48); these groups of
isolates are also typically low toxin producers [22].
While other temperate phages in E. coli O157:H7 are in-
ducible [52], we only obtained sufficient DNA to close
genomes for two others isolated from PA2 and PA8 that
are related to a phage designated Sp7 in strain Sakai
[30]. In contrast, the coverage for all stx2a-converting
phages sequenced here was 117–573-fold. This data is
consistent with the observations that most prophage in
the E. coli O157:H7 genome are defective [52] and that
the genome copy number of stx2a-converting phage
upon mitomycin C induction is at least two orders of
magnitude higher than for other prophages.
Previous studies suggested that genetic polymorphisms
between stx2a-converting phage genomes could impact
levels of toxin production [20, 23, 53]. Our study identi-
fied eight new genotypes of stx2a-converting phage,
almost doubling the number of complete phage genomes
Fig. 6 O157:H7 whole genome phylogeny and stx2a-converting
phage PST comparison suggests multiple acquisitions of
PST2 phages. Whole bacteria genomes of 45 O157:H7 strains
were aligned using Mugsy [44]. The phylogenetic tree was
inferred using RaxML with 1000 bootstrap replicates [45],
and visualized as a cladogram due to high variation in branch
length. PST1, PST2, and PST3 clusters are shaded in yellow,
light purple and orange respectively. Corresponding metadata
were added with Evolview [79]
Fig. 7 Host factors modulate stx2a expression levels. (a) Whole
genomes of 14 O157:H7 strains with PST1-1 were aligned using
Mugsy [44] and the phylogenetic tree was inferred using RaxML
[45] with 100 bootstrap replicates and visualized using Figtree
[88]. (b) Stx2 production was quantified by ELISA 2 h after cipro-
floxacin induction. Bars labeled with different letters were signifi-
cantly different (P < 0.05)
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varieties deposited. We observed that one major driving
force of phage genome diversity is in IS629 copy number
and location variations. This is in accordance with previ-
ous studies that identified multiple copies of IS629,
especially in the prophage, prophage-like and plasmid
regions [24, 25, 54, 55]. This provides us with several
testable hypotheses for how polymorphisms in the phage
genome may impact toxin levels. For example, stx2a
expression and subsequent release of toxin from the bac-
teria requires induction of the lytic cycle. Noteworthy,
we observed a disruption of a putative roi in PST1-3 and
PST1-6, which encodes a DNA-binding protein that
inhibits the activation of the lytic cycle [56]. Therefore,
we speculate that the specific IS629 insertion in PST1-3
and PST1-6 may increase toxin production in strains
carrying these phage sequence types. Once Stx2 is
produced, efficient release of the toxin requires lysis
of the bacteria. In PST1-5, the gene encoding a putative
lysozyme was disrupted which could reduce the amount
of toxin released. Inactivation of adenine DNA methyl-
transferase genes such as that observed in PST2-1 may
additionally affect toxin production through de-repressing
the lytic cycle [57].
The other major source of phage genome diversity, as
noted before [19], was located within early regulatory
regions. The diversity of this region is driven by homolo-
gous recombination between different lambdoid pro-
phages [30, 58, 59]. Previous studies have also suggested
that polymorphisms in early regulatory genes could lead
to differential stx expression [23, 37, 38]. For example,
the cooperative binding of CI dimers to operator sites
designated OL and OR maintains the phage in its lyso-
genic state through repressing transcription from the PL
and PR promoters, respectively. The copy number of
each operator site can vary, for example E. coli O157:H7
strain EDL933 has two OL sites surrounding PL that are
designated OL1 and OL2, while the strain Sakai also has
an OL3 [37]. Four hours post antibiotic phage-induction,
Stx2a production is greater for EDL933 than Sakai [60],
and one reasonable hypothesis could be that this is
caused by decreased repression at OL [37, 38]. As with
the PST1 phage from Sakai, our PST3 phage also had
three identifiable OL and OR sites, however, we were un-
able to identify operator sequences or some early regula-
tory genes in the PST2 cluster phages. Whether one or
more of these differences are responsible for the reduced
quantities of toxin produced by strain PA2 compared to
Sakai and EDL933 [60] remains to be determined.
Both PST2 and PST3 phages are found within clade 8
of E. coli O157:H7, which is a subgroup associated with
high incidence of hospitalization and HUS [14, 15]. We
found that PST2 phages were highly similar to the Stx2a
phage of E. coli O104:H4 2011C-3493, a Stx2a-expressing
enteroaggregative E. coli (EAEC) that was responsible for
a severe outbreak in Germany in 2011 [41]. A related
phage designated TL-2011C (Fig. 4) is found within
the genome of an E. coli O103:H25 strain that caused a
small outbreak in Norway [43] that again was charac-
terized by a high HUS rate. Future research should
investigate whether these phages are indicators of high
Stx2a producing strains.
Diversity within the phage genome undoubtedly plays
an important role in toxin production, however other
factors encoded within the host may also influence the
phage lifestyle [61]. Our assembly of phage genomes
identified several E. coli O157:H7 strains carrying identi-
cal stx2a-converting prophages that were integrated at
the same genomic site. Importantly, all of these strains
also contain stx1-converting phage, which are known to
decrease Stx2 production in E. coli O157:H7 strains car-
rying both phages [27]. Thus, by using wild-type clinical
isolates that have been minimally passaged since isolation,
we could test the hypothesis that genes external to the
phage impact toxin production. Indeed, we observed a
greater than five-fold variation in Stx2 production
between PA4 and PA44, demonstrating that future studies
investigating the mechanism(s) behind differences in Stx
expression must take both phage and chromosomal host
background into consideration. We also noted some
discordance between toxin protein and transcript levels
(Fig. 7), which is similar to observations with E. coli
O157:H7 strain TW08612 [51]. This suggests that caution
must be taken when assessing potential virulence of E. coli
O157:H7 by qPCR alone. The identification of highly simi-
lar phage was also observed with stx2-converting phage
from E. coli O104:H4 isolates [62], highlighting a remark-
able stability contrasted to the mosaic structure that also
exists between phage as reported here and elsewhere [63].
Although a single acquisition of the stx2a-converting
phage was suggested in the well-established stepwise evo-
lution model from O55:H7 to O157:H7 [10, 11, 13], pro-
phage regions are also known as hotspots of horizontal
gene transfer. Laing et al. [40] used both complete gen-
ome and WGS to compare stx-converting phage phyl-
ogeny with their host bacterial phylogeny and found that
the two phylogenies generally agree with each other.
However, the phage genomes extracted from WGS
were not necessarily fully assembled and this may have
influenced the accuracy of this analysis [40]. Unlike
most whole genome shotgun sequencing studies,
which do not allow for precise assembly of stx-convert-
ing phage regions, our study accomplished this by
enriching for and sequencing phDNA after removal of
bacterial genomic DNA. Our data suggest that PST1
phages in general evolved vertically along with the
host. We did however observe that E. coli O157:H7
strains PA2 and PA8, both of which carry PST2 phages,
occupy distinct nodes on the tree generated from
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whole genome alignments (Fig. 6). While it is possible
that this demonstrates mobilization of the PST2
phages, our limited genomic data set is clearly insuffi-
cient to make any firm conclusions.
Conclusion
This study expands our knowledge of the genetic
diversity within stx2a-converting phages, and suggests
that both phage and bacterial sequences, as well as
phage insertion sites modulate Stx2 production.
Sequencing additional stx2a-converting phages is justi-
fied, but should probably use other approaches as the
strategy we took may bias results towards high phage
producing strains. Next Generation Sequencing (NGS)
long read technologies, such as PacBio, have been used
by other investigators for accurate phage genome
assemblies when other (related/homologous) phages
are present as well [64]. As a larger number of complete
genomes become available, a more comprehensive com-
parison to other Enterobacteria phage lambda will be
possible that accounts for exchange of phage through
genetic recombination, establishing whether the phage
genotypes described could be considered distinct spe-
cies. This study also serves as robust foundation for
future work investigating whether the phage genome
polymorphisms observed impact the virulence pheno-
type, particularly Stx2 production, both in pure culture
and in combination with other members of the gut
microbiota.
Methods
Bacterial strains and culture media
The 45 E. coli O157:H7 isolates used in this study were
obtained from the Pennsylvania Department of Health
and were originally characterized by Hartzell et al.
(2011) [28]. All isolates were stored at −80 °C in 10 %
glycerol and grown in Luria-Bertani (LB) [65] at 37 °C.
Phage DNA isolation and sequencing
Phage DNA (phDNA) was isolated as previously de-
scribed [66]. Briefly, each of the 45 isolates (Additional
file 1: Table S1) was grown overnight in LB at 37 °C
with constant shaking. To induce the phages’ lytic cycle,
each overnight culture was diluted in LB supplemented
with 45 ng/ml ciprofloxacin to an optical density of 0.05
at 600 nm (OD600) and incubated for 8 h at 37 °C with
shaking. Supernatants were collected after centrifugation
(4000 × g, 10 min, 4 °C) and filtration (0.2-μm cellulose
acetate filter; VWR, Philadelphia, PA) and treated with 0.6
Unit/ml DNase I (Promega, Madison, WI) and 1.8 μg/ml
RNase (Promega, Madison, WI) at 37 °C for 1 h to digest
gDNA and RNA. The treated supernatants were incubated
o/n with 10 % (wt/vol) polyethylene glycol 8000 (Promega,
Madison, WI) and 1 M NaCl at 4 °C. After centrifugation
(5000 × g, 2 h, 4 °C), each pellet was resuspended in SM
buffer (0.58 % NaCl, 0.2 % MgSO4 · 7H2O, 1 M Tris-Cl
[pH 7.5], and 0.01 % gelatin) and treated with 50 μg/ml
proteinase K (EMD, Darmstadt, Germany) at 65 °C for 1 h
to digest the phage capsid protein and release phDNA. A
phenol-chloroform (1:1 vol/vol) extraction was performed
to remove protein and the Clean and Concentrator kit
(Zymo Research, Irvine, CA) was used to further purify
and concentrate phDNA. The double-strand DNA
(dsDNA) was quantified using the dsDNA BR assay kit
(Qubit, Grand Island, NY). Purified phDNA (>200 ng)
was sequenced using a Roche GS 454 FLX+ system (454
Life Science, Branford, CT) at the Penn State Genome
Core Facility. Sequencing of gDNA was performed by the
University of Maryland Institute for Genome Sciences on
the Illumina HiSeq 2000.
Phage genome assembly
The phDNA reads for each of the 22 isolates were
assembled de novo using SeqMan NGen (DNASTAR,
Madison, WI). The average sequencing depth ranged
from 117 to 573. For each isolate, BLAST analysis of
contigs (>1000 bp) was performed against the non-
redundant nucleotide database in GenBank to identify
the best matching phage genome to use as a reference
for scaffold building. Reference genomes were VT2Phi
(accession HQ424691) [40, 67] for strains PA2 and PA8,
E. coli O157:H7 EC4115 (accession CP001164) [53] for
strain PA28, and Sakai (accession BA000007) [30] for
the remaining phage. Gaps were closed by manual cur-
ation, and the draft genome was corrected for homopol-
ymers using Illumina gDNA reads previously generated
from the E. coli O157:H7 host strain (Additional file 1:
Table S1). Finally, PCR followed by DNA sequencing
was used to validate the location of the IS elements
within the phages.
Phage genome annotation
Phage genomes were auto-annotated using RAST [68]
and PHAST [69]. The GenBank files generated by RAST
were then manually curated in Artemis [70] using the
following principles: (i) prophage integration sites and
tRNA genes carried by the phage were identified by
PHAST, if present; (ii) open reading frames (ORFs) pre-
dicted to encode proteins of 39–94 amino acids, when
present on the opposite DNA strand from and overlap-
ping a predicted operon, were deleted if no known func-
tion had been ascribed to that ORF; (iii) if RAST and
PHAST identified a different start codon for the same
ORF, the Glimmer-based [71] prediction of PHAST was
followed; (iv) ORFs identified by RAST but not PHAST
were kept if one of the following was observed: a BLAST
match was identified with a gene of known function, a
Pfam motif was identified [72], Psortb [73] identified at
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least one secondary structure feature, or Fugue [74]
returned a match with confidence interval greater than
99 % ; (v) for ORFs identified by PHAST but not RAST,
guideline iv was followed except the Fugue confidence
interval was reduced to greater than 95 %. A few excep-
tions to these rules exist: (a) in PA2, PA8 and PA28, the 3’
end of the integrase overlaps with the 3’ end of the down-
stream ORF, however both ORFs were annotated; (b) in
PA45, ORF49 and 50 are predicted to be convergently
transcribed and overlap at their stop codons. We kept
these ORFs since guideline iv and v supported each.
Comparative genome analysis
Illumina HighSeq reads were mapped to assemblies with
CLC Genomics Workbench 7.04 (CLC Bio) to assess
quality and coverage of predicted SNPs. All SNPs had a
coverage above 100 × and Phred scores of 64. Phage
genome alignments were generated with progressive
Mauve [75] and visualized with Geneious R7.1.7. [76].
Comparisons of gene and protein sequences were per-
formed using ClustalW packaged in MegAlign (DNAS-
TAR Inc, Madison, WI) to identify SNPs and calculate
sequence percent identities. BLASTN alignments of
phage genomes were visualized using EasyFig [34, 77].
Phylogenetic trees
Multiple sequence alignments were performed via
Mugsy for whole genome alignments of both E. coli
chromosomal and phage genomes [44]. The alignment
was then imported into Galaxy [78] to convert the MAF
alignment file into a fasta file containing a single entry
per strain. The maximum likelihood phylogenetic trees
were inferred using RAxML V7.2 [45], with the following
parameters: rapid bootstrapping and GTRGAMMA with
100 and 1000 bootstraps for chromosomes and phages,
respectively. Trees and strain-associated metadata were
visualized with Evolview [79].
The phage genome tree that includes phages from
GenBank was generated using the method and parame-
ters described by Laing et al. [40]. Panseq [39] was used
to cut phage genomes into 500 bp fragments. The “core
genome” was defined by combining fragments present
in ≥ 3 phage genomes at > 85 % identity. Other param-
eters were ‘nucB’ = ‘200’, ‘nucC’ = ‘50’, ‘nucD’ = ‘0.12’,
‘nucG’ = ‘100’ and ‘nucL’ = ‘11’. The presence or absence
of core genome fragments in each phage genome was
used for clustering. Uncorrected P-distance was used to
build a neighbor-joining tree by SplitsTree 4 [80].
BLAST Score Ratio Analysis
The phage proteome for each of the 9 phages sequence
types were predicted using the Prodigal [81] gene predic-
tion software. The concatenated predicted ORFs were
then de-replicated with Usearch [82] and run through
comparative BLAST score ratio (BSR) analysis [31] using
TBLASTN [34]. For each of the predicted proteins, a
BLASTP raw score was obtained for the alignment
against itself (REF_SCORE) and the most similar pro-
tein (QUE_SCORE) in each of the genomes. Dividing
the QUE_SCORE obtained for each query genome pro-
tein by the REF_SCORE normalized these scores and
constitutes the BLAST score ratio (BSR). Proteins with
a normalized BSR of <0.4 were considered to be non-
homologous. A normalized BSR of 0.4 correspond to
two proteins being 30 % identical over their entire
length [31, 83].
Stx2 gene expression and toxin production
Stx2 gene expression and toxin production was quanti-
fied using reverse transcription-qPCR and ELISA, re-
spectively. Briefly, overnight LB cultures of each strain
were diluted to an OD600 of 0.05 with fresh LB media
supplemented with 40 ng/mL of ciprofloxacin [84] and
incubated for 2 h at 37 °C with shaking. For reverse
transcription-qPCR, total RNA was isolated using the
Ambion PureLink mini kit (Life Technologies, Grand
Island, NY). The RNA quantity and quality was assessed at
absorbance of 260 nm using UV-spectrophotometer. RNA
was treated with amplification grade DNase I (Invitrogen,
Grand Island, NY) and used for cDNA synthesis with the
Masterscript kit (5 PRIME, Gaithersburg, MD). The primer
pairs for stx2a (5’-TCCCGTCAACCTTCACTGTA-3’ and
5’-GCGGTTTTATTTGCATTAGC-3’, target subunit B
gene) [85] and tufA (5’-TGGTTGATGACGAAGAGCTG-
3’ and 5’- GCTCTGGTTCCGGAATGTAA-3’) [86] were
used in conjunction with Go-Taq® qPCR Master Mix (Pro-
mega, Madison, WI) and MicroAmp Fast optical real-time
96-well PCR plates (Applied Biosystems, Grand Island, NY)
in an ABI StepOne PLUS Real-Time PCR system (Applied
Biosystems, Grand Island, NY). Dissociation curves were
analyzed for all reactions to verify single peaks/products.
Expression levels of stx2a were normalized against tufA
using ABI StepOne PLUS System SDS software (Ap-
plied Biosystems, Grand Island, NY) and shown in
relative quantity (RQ). Three biological replication
were conducted for each strain. For ELISA analysis,
pre-warmed polymyxin B (6 mg/mL) was added to the in-
duced culture and incubate for 10 min at 37 °C to lyse all
the bacteria. Supernatants were collected after centrifuga-
tion (4000 × g, 10 min, 25 °C) and diluted to measurable
concentrations. The 96 well polystyrene microtiter strip
plates (Thermo Scientific, Waltham, MA) coated with
2.5 μg of ceramide trihexoside (Matreya Biosciences, Pleas-
ant Gap, PA) were used for ELISA. After coating, the plates
were incubated o/n at 4 °C with blocking buffer (4 %
bovine serum albumin in 0.01 M phosphate buffer saline
with 0.05 % Tween20). Samples (100 μl) were added to
each well and incubated for 1 h at room temperature with
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shaking. After removing the samples, the wells were
washed with PBS-Tween (PBST) buffer for five times.
Mouse anti-Stx2 (Santa Cruz Biotech, Santa Cruz CA)
(1 μg/ml, 100 μl) was added to each well. Plates were incu-
bated for 1 h at room temperature with shaking,
followed by five PBST washes. Goat anti-mouse IgG
peroxidase conjugated (0.1 μg/mL, 100 μl) secondary
antibody was added and incubated for 1 h at room
temperature with shaking. After five PBST washes,
100 μl of 1-Step Ultra TMB (3,3’,5,5’ tetramethylbenzidine)
was added to each well, and the plates were incubated for
10 min at room temperature followed by the addition of
an equal volume of stopping solution (2 M H2SO4). The
OD at 450 nm was examined using a spectrophotometer.
A standard curve was constructed for each plate and three
technical repeats were performed for each sample. Total
protein for each sample was measure using the Bradford
assay. Three biological replicates were conducted for each
strain. Data were analyzed using one-way analysis of
variance (ANOVA) and Tukey’s test by R Version 3.0.2.
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